EUVIMEDEUVIMED entdecken
Crossref

Prospective Evaluation of WHO and European Clinical, Molecular and Pathological (WHO-ECMP) Criteria for Myeloproliferative Neoplasms (MPN) of Various Molecular Etiology: Characteristics of JAK2V617F, MPL515 and CALR Mutated MPN

Michiels JJ, Devos T, Fostier K, Valster FA, Potters V, Schelfout K, Raeve HD

Journal of Hematology and Blood Disorders · 2015

DOI: 10.15744/2455-7641.1.104 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Hematology and Blood Disorders, 2015. Verfasst von Michiels JJ und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

JJ, M., T, D., K, F., FA, V., V, P., K, S., & HD, R. (2015). Prospective Evaluation of WHO and European Clinical, Molecular and Pathological (WHO-ECMP) Criteria for Myeloproliferative Neoplasms (MPN) of Various Molecular Etiology: Characteristics of JAK2V617F, MPL515 and CALR Mutated MPN. Journal of Hematology and Blood Disorders. https://doi.org/10.15744/2455-7641.1.104

Vancouver

JJ M, T D, K F, FA V, V P, K S, et al. Prospective Evaluation of WHO and European Clinical, Molecular and Pathological (WHO-ECMP) Criteria for Myeloproliferative Neoplasms (MPN) of Various Molecular Etiology: Characteristics of JAK2V617F, MPL515 and CALR Mutated MPN. Journal of Hematology and Blood Disorders. 2015. doi:10.15744/2455-7641.1.104

BibTeX
@article{JJ2015,
  author = {JJ, Michiels and T, Devos and K, Fostier and FA, Valster and V, Potters and K, Schelfout and HD, Raeve},
  title = {Prospective Evaluation of WHO and European Clinical, Molecular and Pathological (WHO-ECMP) Criteria for Myeloproliferative Neoplasms (MPN) of Various Molecular Etiology: Characteristics of JAK2V617F, MPL515 and CALR Mutated MPN},
  journal = {Journal of Hematology and Blood Disorders},
  year = {2015},
  doi = {10.15744/2455-7641.1.104}
}
Kostenlos starten →